An Alternate Factor Creating False Magnification of the Ratio of the Two Cardiac Biomarkers

Pandey et al demonstrated a novel finding about utility of cardiac biomarkers to differentiate type 1 and type 2 myocardial infarction (MI) in a recently published article entitled “A Comparison of Biomarker Rise in Type 1 and Type 2 Myocardial Infarction.”1 From the viewpoint of clinical practices, finding new methods to distinguish type 1 MI from type 2 MI is important because the initial approaches and aims of treatment are different between these types. Although cardia c troponin T (cTnT) is preferred over creatine kinase MB (CK-MB) due to its higher sensitivity and specificity, CK-MB assay is still widely available and has not completely been eliminated.
Source: The American Journal of Medicine - Category: General Medicine Authors: Tags: Letter Source Type: research